Evaluation of an NGS Assay for Detecting RNA Fusions and Splicing Events in Lung Cancer
Thursday, November 2, 2017
Tweet
Transcript
Embed
Email
Bookmark
<<
<
>
>>
Tweet
Facebook
Email
Chapters
Introduction
QuantideX
®
NGS Assays: An Integrated System
Targeted Fusion Detection is a Binary Event
QuantideX
®
NGS RNA Lung Cancer Kit Content
3'/5' Expression Imbalances Expose Novel Fusion Events
MET Exon 14 Skipping is Identified through Targeted Designs
QuantideX
®
NGS RNA Lung Cancer Kit Workflow
Amplifiable RNA Inputs Predict Library Quality in NGS
Sample-Aware™ Informatics Software
QuantideX
®
NGS Reporter
Specificity of Fusion Detection
Analytical Sensitivity
Multi-omic NGS Analysis Reveals Multiple Molecular Subtypes
Evaluation of QuantideX
®
NGS RNA Lung Cancer Kit
Clinical Relevance of ALK and ROS1 Translocations in NSCLC
DNA FISH for ALK and ROS1 Translocations
QuantideX
®
NGS RNA Lung Cancer Kit
Evaluation Program Overview
Evaluation Sample List
Comparison of Total Reads Passing Filter
Mapped Reads Passing Filter for Positive Samples
Concordance, Intra and Inter Reproducibility
Assessment of Translocations by Asuragen QuantideX
®
and NanoString Vantage
™
Workflow: Hands-on and Total Time
Assessment Conclusions
Multisite Evaluation Results Concordance
No transcript for this webinar
More Information
Request info